A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Name: A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Published: 2024
License: Public Domain

Novartis Pharmaceuticals · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

systemic

lupus erythematosus, systemic, lupus nephritis, chimeric antigen receptor-t (car-t), rapcabtagene autoleucel, lupus nephritis (ln), systemic lupus erythematosus (sle), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Related documents